HepaSH Sustainable Human Hepatocytes

Powered by CIEM

Marketed WW by Biopredic International

 

HepaSH Features

  • Sustainability
  • Consistency
  • Robustness
  • Functional performance
  • Long-Term Viability
  • Multidonor set
  • Zero stock policy
  • Data base

HepaSH Technology


Contact Us

HepaSH Standardization Technology

HepaSH Morphology and Life Style

Hepatic markers expression

HepaSH Metabolically Competent HH

HepaSH CYP Inducibility

Transporters

Contact Us

HepaSH Production and Shipment Schedule

HepaSH Donor Information

Fresh Suspended Ready-to-plate HepaSH

FSSH001: 5.106 cell/vial  1x 96-multi well plate


  1. Provided as fresh suspended hepatocytes

  2. 3 donors available as of now

    Donor 1: Female, Caucasian, 12 years old. Donor 2: Male, Caucasian, 3 months. Donor 3: Male, Caucasian, 5 years old

  3. William E- based cell culture medium

  4. Can be maintained for up to 14 days in 2D culture

  5. 2 production sessions/month

  6. Our commitments: cell viability, number of viable cells, human cell percentage, sterility

Check HepaSH™ Related News

Our services on HepaSH human hepatocytes

Our services on HepaSH human hepatocytes

News

HEPARG
Mar 6, 2026

News test

Nouvelles publications du mois

Read more
BIOPREDIC
Feb 20, 2026

SSX India, Annual conference of the Society for the Study of Xenobiotics (SSX)

SSX India

Read more
EUROSAFE
Feb 5, 2026

TMG Visit — Tokyo Expansion Project

TMG Visit — Tokyo Expansion Project

Read more
View all

Contact Us